Toggle navigation
Home
Search
Services
Blog
Contact
About
Complement Activation and Cardiopulmonary Bypass
Rollins, Scott A.
Alexion Pharmaceuticals, Inc., Cheshire, CT, United States
Search 17 grants from Scott Rollins
Search grants from Alexion Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Genetic Markers of CHD in Type 2 Diabetes
PS06-607, Enhanced HIV/AIDS Surveillance for Perinatal Prevention
A Phase I, Open-Label Safety and Tolerability Study of Oral Thera CLEC-Total
Airway Effects of Repeated Exposures to Ozone in Healthy and Asthmatics
Childrens Cancer Study Group
Recently added grants:
Psychological and brain mechanisms underlying disparities in opioid and non-opioid pain treatment decisions
Single-molecule analysis of eukaryotic transcription activation
Effectivenss of an Integrated Treatment to Address Smoking Cessation and Anxiety/Depression in People Living with HIV
Reduction of intracochlear fibrosis and bacterial infection using photopolymerized durable zwitterionic coatings on cochlear implant biomaterials
High School Program in Biomedical and Health Sciences
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44HL052365-03
Application #
2029136
Study Section
Special Emphasis Panel (ZRG4-HEM-2 (02))
Project Start
1994-09-30
Project End
1997-08-31
Budget Start
1996-09-05
Budget End
1997-08-31
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Alexion Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Cheshire
State
CT
Country
United States
Zip Code
06410
Related projects
NIH 1996
R44 HL
Complement Activation and Cardiopulmonary Bypass
Rollins, Scott A. / Alexion Pharmaceuticals, Inc.
NIH 1995
R44 HL
Complement Activation and Cardiopulmonary Bypass
Rollins, Scott A. / Alexion Pharmaceuticals, Inc.
Comments
Be the first to comment on Scott Rollins's grant